Clinical Trials Browser

Phase 1/2 × Clarithromycin × Plasma cell × Clear all

NCT02343042 2025-12-22

STOMP

Phase 1/2 Recruiting

Multiple Myeloma, Recurrence

NCT02542657 2024-09-19

Ixazomib with Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients with Multiple Myeloma

Phase 1/2 Active not recruiting

Neoplasms, Plasma Cell